GENE ONLINE|News &
Opinion
Blog

2026-04-10|

Zinc Oxide Nanoparticles Synthesized from Oxystelma Esculentum Show Antimicrobial and Antioxidant Properties

by GOAI
Share To

Researchers have successfully synthesized zinc oxide nanoparticles (ZnO-NPs) using an extract from Oxystelma esculentum, a medicinal salt-tolerant plant species. The study highlights the biological activities of these phytofabricated nanoparticles, which were developed through an eco-friendly and sustainable approach utilizing plant-based materials.

The investigation focused on the multifunctional properties of the ZnO-NPs, including their antimicrobial, antioxidant, and cytotoxic effects. The researchers employed advanced characterization techniques to confirm the successful synthesis of the nanoparticles and evaluate their structural and functional attributes. Tests demonstrated that these nanoparticles exhibited significant antibacterial activity against various pathogens, as well as notable antioxidant properties that could counteract oxidative stress. Additionally, cytotoxicity assessments revealed potential applications in targeting cancer cells. This study underscores the potential of plant-derived nanomaterials in biomedical and environmental fields while emphasizing sustainable production methods.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 10, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
RadNet Announces Record Q1 Results and Raises 2026 Financial Guidance
2026-05-10
*Catharanthus roseus* Cells Show Varied Antioxidant Response to *Schizophyllum commune* Mycelium Extract Versus Filtered Culture Medium
2026-05-10
Faraday Future Appoints YT Jia as CEO, Jerry Wang as Executive Chairman
2026-05-10
Contagious Yawning May Start in the Womb, Study in *Current Biology* Reveals
2026-05-10
New Medication Combinations Show Promise for Treatment-Resistant Depression in *JAMA Psychiatry* Study
2026-05-10
Ellomay Capital Completes Sale of Dorad Energy Holdings on May 10, 2026
2026-05-10
Digitalis Glycosides Studied for Heart Failure Treatment at ESC Heart Failure 2026 Congress
2026-05-10
Scroll to Top